These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 37525282)

  • 1. Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions.
    Fu DJ; Wang T
    J Hematol Oncol; 2023 Jul; 16(1):87. PubMed ID: 37525282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAE modulators: A potential therapy for gastric carcinoma.
    Liang Q; Liu M; Li J; Tong R; Hu Y; Bai L; Shi J
    Eur J Med Chem; 2022 Mar; 231():114156. PubMed ID: 35131538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
    Zhao Y; Morgan MA; Sun Y
    Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus.
    Flores-Martínez YA; Le-Trilling VTK; Trilling M
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy.
    Nawrocki ST; Griffin P; Kelly KR; Carew JS
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1563-73. PubMed ID: 22799561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models.
    Yoshimura C; Muraoka H; Ochiiwa H; Tsuji S; Hashimoto A; Kazuno H; Nakagawa F; Komiya Y; Suzuki S; Takenaka T; Kumazaki M; Fujita N; Mizutani T; Ohkubo S
    Mol Cancer Ther; 2019 Jul; 18(7):1205-1216. PubMed ID: 31092565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cells.
    Xu GW; Toth JI; da Silva SR; Paiva SL; Lukkarila JL; Hurren R; Maclean N; Sukhai MA; Bhattacharjee RN; Goard CA; Medeiros B; Gunning PT; Dhe-Paganon S; Petroski MD; Schimmer AD
    PLoS One; 2014; 9(4):e93530. PubMed ID: 24691136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication.
    Jiang Y; Jia L
    Anticancer Agents Med Chem; 2015; 15(9):1127-33. PubMed ID: 25742093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical Inhibition of Neddylation as Promising Treatments for Various Cancers.
    Yin L; Xue Y; Shang Q; Zhu H; Liu M; Liu Y; Hu Q
    Curr Top Med Chem; 2019; 19(12):1059-1069. PubMed ID: 30854973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overactivated neddylation pathway as a therapeutic target in lung cancer.
    Li L; Wang M; Yu G; Chen P; Li H; Wei D; Zhu J; Xie L; Jia H; Shi J; Li C; Yao W; Wang Y; Gao Q; Jeong LS; Lee HW; Yu J; Hu F; Mei J; Wang P; Chu Y; Qi H; Yang M; Dong Z; Sun Y; Hoffman RM; Jia L
    J Natl Cancer Inst; 2014 Jun; 106(6):dju083. PubMed ID: 24853380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer.
    Li L; Kang J; Zhang W; Cai L; Wang S; Liang Y; Jiang Y; Liu X; Zhang Y; Ruan H; Chen G; Wang M; Jia L
    EBioMedicine; 2019 Jul; 45():81-91. PubMed ID: 31208947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOMCL-19-133, a novel, selective, and orally available inhibitor of NEDD8-activating enzyme (NAE) for cancer therapy.
    Zhou LN; Xiong C; Cheng YJ; Song SS; Bao XB; Huan XJ; Wang TY; Zhang A; Miao ZH; He JX
    Neoplasia; 2022 Oct; 32():100823. PubMed ID: 35907292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
    Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
    Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage display to identify Nedd8-mimicking peptides as inhibitors of the Nedd8 transfer cascade.
    Zhao B; Zhang K; Villhauer EB; Bhuripanyo K; Kiyokawa H; Schindelin H; Yin J
    Chembiochem; 2013 Jul; 14(11):1323-30. PubMed ID: 23824602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neddylation: a novel modulator of the tumor microenvironment.
    Zhou L; Jiang Y; Luo Q; Li L; Jia L
    Mol Cancer; 2019 Apr; 18(1):77. PubMed ID: 30943988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.
    Zhou H; Lu J; Yang CY; Sun Y; Wang S
    Adv Exp Med Biol; 2020; 1217():349-362. PubMed ID: 31898237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ.
    Brownell JE; Sintchak MD; Gavin JM; Liao H; Bruzzese FJ; Bump NJ; Soucy TA; Milhollen MA; Yang X; Burkhardt AL; Ma J; Loke HK; Lingaraj T; Wu D; Hamman KB; Spelman JJ; Cullis CA; Langston SP; Vyskocil S; Sells TB; Mallender WD; Visiers I; Li P; Claiborne CF; Rolfe M; Bolen JB; Dick LR
    Mol Cell; 2010 Jan; 37(1):102-11. PubMed ID: 20129059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Double-Edged Effects of MLN4924: Rethinking Anti-Cancer Drugs Targeting the Neddylation Pathway.
    Tang H; Pang X; Li S; Tang L
    Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neddylation Inactivation Facilitates FOXO3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity.
    Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM
    Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
    Yao WT; Wu JF; Yu GY; Wang R; Wang K; Li LH; Chen P; Jiang YN; Cheng H; Lee HW; Yu J; Qi H; Yu XJ; Wang P; Chu YW; Yang M; Hua ZC; Ying HQ; Hoffman RM; Jeong LS; Jia LJ
    Cell Death Dis; 2014 Feb; 5(2):e1059. PubMed ID: 24525735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.